Gano Kyleinsider trades
In SEC Form 4 filings, Gano Kyle is listed as Chief Executive Officer of Neurocrine Biosciences Inc (NBIX). Gano Kyle reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 15.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| NBIXNeurocrine Biosciences Inc | Chief Executive Officer | 4 | Sep 15 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-15
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| NBIXNeurocrine Biosciences Inc | Sep 11 | Sep 15 | A | 6,275 | $0.00 | $0 | 157,266 | No | Form 4 |
| NBIXNeurocrine Biosciences Inc | Sep 11 | Sep 15 | F | 3,386 | $156.22 | $528,961 | 153,880 | No | Form 4 |
| NBIXNeurocrine Biosciences Inc | Sep 11 | Sep 15 | A | 1,842 | $0.00 | $0 | 155,722 | No | Form 4 |
| NBIXNeurocrine Biosciences Inc | Sep 11 | Sep 15 | F | 994 | $156.22 | $155,283 | 154,728 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.